WuXi Biologics (Cayman) Aktie

6,20 EUR -0,25 EUR -3,88 %

08:06:04

FSE

Aktien, ETFs, Sparpläne & Kryptos zu Top-Konditionen beim Testsieger von finanztip.de handeln!

JETZT LOSLEGEN

Du hast schon ein ZERO-Konto? Direkt handeln bei ZERO!Bei einem anderen Broker handeln Smartphone

KGV19,38Div. Rendite0,00%

WKNA2PQ3Q

ISINUS98260N1081

SymbolWXXWY

WuXi Biologics (Cayman) Aktien News

Sortieren:Datum Meistgelesen

25.03.25PR NewswireWuXi Biologics Reports Solid 2024 Annual Results and Expects Accelerated Growth in 2025

24.03.25PR NewswireWuXi Biologics Receives CDMO Leadership Awards for Eighth Consecutive Year

21.03.25PR NewswireWuXi Biologics Named to CDP Water Security "A List" for Second Consecutive Year

WerbungWuXi Biologics (Cayman)-Aktie für 0 Euro (zzgl. Spreads) handeln bei finanzen.net zero

11.03.25PR NewswireWuXi Biologics Included in S&P Global Sustainability Yearbook 2025

04.03.25PR NewswireWuXi Biologics Launches EffiX™ Microbial Expression Platform to Boost Recombinant Protein and Plasmid DNA Production

27.02.25PR NewswireWuXi Biologics Again Passed GMP Inspection by Japan PMDA

18.02.25PR NewswireWuXi Biologics Awarded Platinum Medal by EcoVadis Sustainability Rating for Second Consecutive Year

10.02.25PR NewswireWuXi Biologics Recognized as Industry and Regional ESG Top-Rated Company by Morningstar Sustainalytics for Fifth Consecutive Year

07.01.25PR NewswireWuXi Biologics Announces Agreement with Candid Therapeutics on Trispecific T-cell Engager

02.01.25PR NewswireWuXi Biologics Ranks Top in 2024 Dow Jones Sustainability Indices for Second Consecutive Year

12.12.24PR NewswireWuXi Biologics Included in UNGC 20 Case Examples of Sustainable Development for 20 Years Collection

06.12.24PR NewswireWuXi Biologics Achieves Major Milestones at Ireland Site with Multiple 16,000L PPQ Success and HPRA GMP Authorizations

14.11.24PR NewswireWuXi Biologics Germany to Enhance Capabilities with New Prefilled Syringes Line

28.10.24PR NewswireWuXi Biologics Launches WuXia™ RidGS for Non-Antibiotic Cell Line Development

16.10.24PR NewswireWuXi Biologics Receives ESG Corporate Platinum Award from The Asset for Fourth Consecutive Year

23.09.24PR NewswireWuXi Biologics Included in Hang Seng ESG 50 Index

30.08.24PR NewswireWuXi Biologics Successfully Completes First Scale-Up of High-Productivity Bioprocessing Platform WuXiUI™ in 2,000L GMP Manufacturing

21.08.24PR NewswireWuXi Biologics Reports Solid 2024 Interim Results

08.08.24PR NewswireWuXi Biologics and Medigene Enter into a Research Collaboration for Off-the-Shelf TCR-Guided T Cell Engagers

01.08.24PR NewswireWuXi Biologics' Four Manufacturing Facilities and Biosafety Testing Center Certified Again by European Medicines Agency for Ten Biologics

10.07.24PR NewswireWuXi Biologics Named Constituent of the FTSE4Good Index Series for Fourth Year

30.04.24PR NewswireWuXi Biologics Releases 2023 ESG Report Demonstrating Strong Sustainability Commitment

26.03.24PR NewswireWuXi Biologics Reports Solid 2023 Annual Results

22.03.24PR NewswireWuXi Biologics Named to CDP 'A List' for Water Security

05.03.24PR NewswireWuXi Biologics Achieves Leadership Level in 2023 CDP Climate Change Assessment

21.02.24PR NewswireWuXi Biologics Recognized as Both Industry and Regional ESG Top-Rated Company by Morningstar Sustainalytics

31.01.24PR NewswireWuXi Biologics Successfully Completes First 16,000L Manufacturing Run in Ireland

31.01.24PR NewswireWuXi Biologics Successfully Completes First 1,6000L Manufacturing Run in Ireland

25.01.24PR NewswireWuXi Biologics Launches WuXia ADCC PLUS™ for the Development and Manufacturing of Afucosylated Antibodies that Elicit Enhanced ADCC Effect

17.01.24PR NewswireWuXi Biologics Granted U.S. Patent for Proprietary Bispecific Antibody Technology Platform WuXiBody™

10.01.24PR NewswireWuXi Biologics Announces Research Service Agreement with BioNTech on Discovering Investigational Monoclonal Antibodies for Developing Next-Generation Therapeutic Product Candidates

WuXi Biologics (Cayman) News

WuXi Biologics (Cayman) News: auf dieser Seite finden Sie alle WuXi Biologics (Cayman) News und Nachrichten zur WuXi Biologics (Cayman) Aktie. Dies beinhaltet die Agentur-Feeds auf finanzen.net, aber auch WuXi Biologics (Cayman) News auf einer Vielzahl externer Seiten. Externe Links sind am entsprechenden Link-Symbol zu erkennen. Um WuXi Biologics (Cayman) News auf externen Seiten zu lesen, folgen Sie einfach dem entsprechenden Link.